A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19.
The study, launched with £2 million of funding from UK Research and Innovation (UKRI) and led by Imperial College London, aims to develop treatment strategies and prevent disability.
Breathlessness is a big problem for many people with long-COVID, particularly on exertion. For people with more severe lung scarring, this can be a devastating disease. Professor Gisli Jenkins Study lead
Many recovering COVID-19 patients suffer from long-term symptoms of lung damage, including breathlessness, coughing, fatigue and limited ability to exercise.
COVID-19 can lead to inflammation in the lungs due to the infection and the immune system’s reaction to it. The inflammation may improve over time, but in some people it persists.